Newsroom Events Social wall Publications Events Social wall Publications Alle Case Study Event Literature Digests Press Releases Literature Digests Novel NKG2D-targeting bispecific antibodies improve B

Technologies Delivering humanized antibodies for safer drugs YUMAB is an expert in fully human antibody development that offers an optimized discovery process tailored to the

Contact Contact form Contact persons Meet us Helpdesk Job applications Newsletter Contact us YUMAB GMBH Science Campus Braunschweig-SüdInhoffenstr. 738124 BraunschweigGermany (+49) 531 481170 0 info@yumab.com

Disclaimer, Data Privacy Statement Controller of the data processing on this website in the sense of the General Data Protection Regulation (GDPR) is: YUMAB GmbHScience

legal notice Address: YUMAB GmbH Science Campus Braunschweig-Süd Inhoffenstr. 738124 Braunschweig – Germany Phone (+49) 531-481170-0 E-Mail: info@yumab.com Commercial Registry: Amtsgericht Braunschweig, HRB 203964 VAT-ID:

Partnering Why partner with us? From target to lead – our mission is to accelerate & de-risk your therapeutic antibody pipeline. YUMAB is your fast-track

Antibody Discovery Powerful discovery process by phage display We support your race towards novel and better immunotherapeutics with our ultra-fast YUMAB® technology platform that combines

Antibody Engineering Improve antibodies for your drug development pipeline Our integrated YUMAB® platform enables not only fast-track discovery but also engineering of existing antibodies. The

Antibody Libraries “The human antibody repertoire in one tube – utilizing nature’s immune library for drug discovery” The perfect start for your drug discovery: YUMAB’s

Career Working at YUMAB YUMAB voices YUMAB Job offers Working at YUMAB Since 2012, YUMAB has been pioneering antibody technologies and services for novel immunotherapies.